Announcements Trials
Browse Landscape

Status

Recruiting 2Active not recruiting 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Observational 3

Sponsor

Cancer Type

Tumor-Agnostic 4Breast 4Thoracic 3Gastrointestinal 3CNS 3Sarcoma 2Other hematologic neoplasm 2Lymphoid 2Gynecologic 2Genitourinary 2Dermatologic 2Plasma cell 1Other 1Myeloid 1Head & Neck 1Classical hematology 1

Conditions

Stomach Neoplasms 15Colorectal Neoplasms 15Pancreatic Neoplasms 11Colonic Neoplasms 9Carcinoma, Hepatocellular 9Esophageal Neoplasms 6Rectal Neoplasms 5Colorectal Neoplasms, Hereditary Nonpolyposis 4Anus Neoplasms 4Neoplasms 3Gastrointestinal Stromal Tumors 3Gastrointestinal Neoplasms 3Gallbladder Neoplasms 3Vulvar Neoplasms 2Uterine Cervical Neoplasms 2Squamous Intraepithelial Lesions 2Peritoneal Neoplasms 2Ovarian Neoplasms 2Melanoma 2Endometrial Neoplasms 2Cholangiocarcinoma 2Bile Duct Neoplasms 2Acquired Immunodeficiency Syndrome 2Vaginal Neoplasms 1Urinary Bladder Neoplasms 1Skin Neoplasms 1Recurrence 1Pseudomyxoma Peritonei 1Prostatic Neoplasms 1Papillomavirus Infections 1

Interventions

Gemcitabine 69Fluorouracil 44pembrolizumab 43Oxaliplatin 42Capecitabine 40Bevacizumab 37Leucovorin 36Irinotecan 31Cisplatin 27Nivolumab 24Paclitaxel 21Cetuximab 21Panitumumab 20130-nm albumin-bound paclitaxel 20Sorafenib 18Albumin-Bound Paclitaxel 18Drug Therapy 15Docetaxel 15Cyclophosphamide 15Radiotherapy 14Blood Specimen Collection 14IFL protocol 12atezolizumab 11Exercise 11Taxes 10budigalimab 9Erlotinib Hydrochloride 9trametinib 8Folfox protocol 8Carboplatin 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Neoplasms × Observation × Gastrointestinal × Clear all
NCT05179824 2025-05-06

Tempus Priority Study: A Pan-tumor Observational Study

Tempus AI

Active not recruiting
1,000 enrolled
BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidOther hematologic neoplasmSarcomaThoracic

Bile Duct Neoplasms, Urinary Bladder Neoplasms, Bone Neoplasms, Brain Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Fallopian Tube Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Laryngeal Neoplasms, Leukemia, Liver Neoplasms, Lung Neoplasms, Lymphoma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Skin Neoplasms, Stomach Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

NCT05234177 2025-05-06

Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays

Tempus AI

Recruiting
300 enrolled
Gastrointestinal

Neoplasms, Colorectal Neoplasms

NCT03303833 2017-10-06

GEOLynch

Wageningen University

Recruiting
1,000 enrolled
Gastrointestinal

Colorectal Neoplasms, Hereditary Nonpolyposis, Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡